Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies

Detalhes bibliográficos
Autor(a) principal: Dias Camara, Diana Aparecida [UNIFESP]
Data de Publicação: 2016
Outros Autores: Mambelli, Lisley Inata, Porcacchia, Allan Saj, Kerkis, Irina
Tipo de documento: Artigo (review)
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.7150/jca.16629
http://repositorio.unifesp.br/handle/11600/49268
Resumo: Cancer cells transformation into a normal state or into a cancer cell population which is less tumorigenic than the initial one is a challenge that has been discussed during last decades and it is still far to be solved. Due to the highly heterogeneous nature of cancer cells, such transformation involves many genetic and epigenetic factors which are specific for each type of tumor. Different methods of cancer cells reprogramming have been established and can represent a possibility to obtain less tumorigenic or even normal cells. These methods are quite complex, thus a simple and efficient method of reprogramming is still required. As soon as induced pluripotent stem cells (iPSC) technology, which allowed to reprogram terminally differentiated cells into embryonic stem cells (ESC)-like, was developed, the method strongly attracted the attention of researches, opening new perspectives for stem cell (SC) personalized therapies and offering a powerful in vitro model for drug screening. This technology is also used to reprogram cancer cells, thus providing a modern platform to study cancer-related genes and the interaction between these genes and the cell environment before and after reprogramming, in order to elucidate the mechanisms of cancer initiation and progression. The present review summarizes recent advances on cancer cells reprogramming using iPSC technology and shows the progress achieved in such field.
id UFSP_c928c17d15f39d51f86a8597e777636a
oai_identifier_str oai:repositorio.unifesp.br/:11600/49268
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologiesGastrointestinal CancerIps CellsHuman FibroblastsDefined FactorsSomatic-CellsGenerationInductionEfficientHypoxiaGenomeCancer cells transformation into a normal state or into a cancer cell population which is less tumorigenic than the initial one is a challenge that has been discussed during last decades and it is still far to be solved. Due to the highly heterogeneous nature of cancer cells, such transformation involves many genetic and epigenetic factors which are specific for each type of tumor. Different methods of cancer cells reprogramming have been established and can represent a possibility to obtain less tumorigenic or even normal cells. These methods are quite complex, thus a simple and efficient method of reprogramming is still required. As soon as induced pluripotent stem cells (iPSC) technology, which allowed to reprogram terminally differentiated cells into embryonic stem cells (ESC)-like, was developed, the method strongly attracted the attention of researches, opening new perspectives for stem cell (SC) personalized therapies and offering a powerful in vitro model for drug screening. This technology is also used to reprogram cancer cells, thus providing a modern platform to study cancer-related genes and the interaction between these genes and the cell environment before and after reprogramming, in order to elucidate the mechanisms of cancer initiation and progression. The present review summarizes recent advances on cancer cells reprogramming using iPSC technology and shows the progress achieved in such field.Laboratory of Genetics, Butantan Institute, Av. Vital Brasil 1500, 05503900 Sao Paulo, SP, BrazilDepartment of Morphology and Genetics, Universidade Federal de Sao Paulo, Sao Paulo, SP, BrazilDepartment of Morphology and Genetics, Universidade Federal de Sao Paulo, Sao Paulo, SP, BrazilWeb of ScienceFAPESP (Sao Paulo Research Foundation) [2010/51051-6]FAPESP: 2010/51051-6Karger2019-01-21T10:29:33Z2019-01-21T10:29:33Z2016info:eu-repo/semantics/reviewinfo:eu-repo/semantics/publishedVersion2296-2303application/pdfhttp://dx.doi.org/10.7150/jca.16629Journal Of Cancer. Lake haven, v. 7, n. 15, p. 2296-2303, 2016.10.7150/jca.16629WOS000393093300017.pdf1837-9664http://repositorio.unifesp.br/handle/11600/49268WOS:000393093300017engJournal Of Cancerinfo:eu-repo/semantics/openAccessDias Camara, Diana Aparecida [UNIFESP]Mambelli, Lisley InataPorcacchia, Allan SajKerkis, Irinareponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-10T00:49:25Zoai:repositorio.unifesp.br/:11600/49268Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-10T00:49:25Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies
title Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies
spellingShingle Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies
Dias Camara, Diana Aparecida [UNIFESP]
Gastrointestinal Cancer
Ips Cells
Human Fibroblasts
Defined Factors
Somatic-Cells
Generation
Induction
Efficient
Hypoxia
Genome
title_short Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies
title_full Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies
title_fullStr Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies
title_full_unstemmed Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies
title_sort Advances and challenges on cancer cells reprogramming using induced pluripotent stem cells technologies
author Dias Camara, Diana Aparecida [UNIFESP]
author_facet Dias Camara, Diana Aparecida [UNIFESP]
Mambelli, Lisley Inata
Porcacchia, Allan Saj
Kerkis, Irina
author_role author
author2 Mambelli, Lisley Inata
Porcacchia, Allan Saj
Kerkis, Irina
author2_role author
author
author
dc.contributor.author.fl_str_mv Dias Camara, Diana Aparecida [UNIFESP]
Mambelli, Lisley Inata
Porcacchia, Allan Saj
Kerkis, Irina
dc.subject.por.fl_str_mv Gastrointestinal Cancer
Ips Cells
Human Fibroblasts
Defined Factors
Somatic-Cells
Generation
Induction
Efficient
Hypoxia
Genome
topic Gastrointestinal Cancer
Ips Cells
Human Fibroblasts
Defined Factors
Somatic-Cells
Generation
Induction
Efficient
Hypoxia
Genome
description Cancer cells transformation into a normal state or into a cancer cell population which is less tumorigenic than the initial one is a challenge that has been discussed during last decades and it is still far to be solved. Due to the highly heterogeneous nature of cancer cells, such transformation involves many genetic and epigenetic factors which are specific for each type of tumor. Different methods of cancer cells reprogramming have been established and can represent a possibility to obtain less tumorigenic or even normal cells. These methods are quite complex, thus a simple and efficient method of reprogramming is still required. As soon as induced pluripotent stem cells (iPSC) technology, which allowed to reprogram terminally differentiated cells into embryonic stem cells (ESC)-like, was developed, the method strongly attracted the attention of researches, opening new perspectives for stem cell (SC) personalized therapies and offering a powerful in vitro model for drug screening. This technology is also used to reprogram cancer cells, thus providing a modern platform to study cancer-related genes and the interaction between these genes and the cell environment before and after reprogramming, in order to elucidate the mechanisms of cancer initiation and progression. The present review summarizes recent advances on cancer cells reprogramming using iPSC technology and shows the progress achieved in such field.
publishDate 2016
dc.date.none.fl_str_mv 2016
2019-01-21T10:29:33Z
2019-01-21T10:29:33Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/review
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format review
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.7150/jca.16629
Journal Of Cancer. Lake haven, v. 7, n. 15, p. 2296-2303, 2016.
10.7150/jca.16629
WOS000393093300017.pdf
1837-9664
http://repositorio.unifesp.br/handle/11600/49268
WOS:000393093300017
url http://dx.doi.org/10.7150/jca.16629
http://repositorio.unifesp.br/handle/11600/49268
identifier_str_mv Journal Of Cancer. Lake haven, v. 7, n. 15, p. 2296-2303, 2016.
10.7150/jca.16629
WOS000393093300017.pdf
1837-9664
WOS:000393093300017
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Journal Of Cancer
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 2296-2303
application/pdf
dc.publisher.none.fl_str_mv Karger
publisher.none.fl_str_mv Karger
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268419713794048